Johnson & Johnson (J&J) is at a critical juncture as it presents its $10 billion settlement proposal to resolve lawsuits alleging its baby powder causes cancer. A Houston judge is set to decide on the company’s third attempt to settle these claims via a subsidiary’s bankruptcy.
About the Author
